Julie Dardare

Rue Du Morvan
Nancy, 54511, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Evaluation of the Idylla IDH1-2 Mutation Assay for the Detection of IDH Variants in Solid Tumors and Hematological Malignancies.

Evaluation of the Idylla IDH1-2 Mutation Assay for the Detection of IDH Variants in Solid Tumors and Hematological Malignancies.

Journal: International journal of molecular sciences

Published: December 03, 2025

Radiotherapy in the management of PDAC, from past to present.

Radiotherapy in the management of PDAC, from past to present.

Journal: Translational oncology

Published: June 25, 2025

A Novel Droplet Digital PCR Assay for BRCA1 and RAD51C Methylation: Advancing Homologous Recombination Deficiency Detection in Ovarian Cancer.

A Novel Droplet Digital PCR Assay for BRCA1 and RAD51C Methylation: Advancing Homologous Recombination Deficiency Detection in Ovarian Cancer.

Journal: The Journal of molecular diagnostics : JMD

Published: February 28, 2025

Improving Radiation Therapy in Pancreatic Cancer Through Radiosensitization Strategies.

Improving Radiation Therapy in Pancreatic Cancer Through Radiosensitization Strategies.

Journal: International journal of radiation oncology, biology, physics

Published: January 22, 2025

Decoding mutational signatures in breast cancer: Insights from a multi-cohort study.

Decoding mutational signatures in breast cancer: Insights from a multi-cohort study.

Journal: Translational oncology

Published: November 25, 2024

Homologous recombination deficiency (HRD) testing landscape: clinical applications and technical validation for routine diagnostics.

Homologous recombination deficiency (HRD) testing landscape: clinical applications and technical validation for routine diagnostics.

Journal: Biomarker research

Published: June 24, 2024

REGN5093-M114: can an antibody-drug conjugate overcome the challenge of resistance to epidermal growth factor receptor and mesenchymal epithelial transition tyrosine kinase inhibitors in non-small cell lung cancer?

REGN5093-M114: can an antibody-drug conjugate overcome the challenge of resistance to epidermal growth factor receptor and mesenchymal epithelial transition tyrosine kinase inhibitors in non-small cell lung cancer?

Journal: Translational lung cancer research

Published: February 13, 2024

DDB2 expression lights the way for precision radiotherapy response in PDAC cells, with or without olaparib.

DDB2 expression lights the way for precision radiotherapy response in PDAC cells, with or without olaparib.

Journal: Cell death discovery

Published: December 21, 2023

ESR1 Gene Mutations and Liquid Biopsy in ER-Positive Breast Cancers: A Small Step Forward, a Giant Leap for Personalization of Endocrine Therapy?

ESR1 Gene Mutations and Liquid Biopsy in ER-Positive Breast Cancers: A Small Step Forward, a Giant Leap for Personalization of Endocrine Therapy?

Journal: Cancers

Published: October 03, 2023

Tumor-derived cell-free DNA and circulating tumor cells: partners or rivals in metastasis formation?

Tumor-derived cell-free DNA and circulating tumor cells: partners or rivals in metastasis formation?

Journal: Clinical and experimental medicine

Published: September 25, 2023

Validation of the Idylla GeneFusion assay to detect fusions and MET exon-skipping in non-small cell lung cancers.

Validation of the Idylla GeneFusion assay to detect fusions and MET exon-skipping in non-small cell lung cancers.

Journal: Scientific reports

Published: March 07, 2023

CRISPR/Cas9-mediated knock-in of BRCA1/2 mutations restores response to olaparib in pancreatic cancer cell lines.

CRISPR/Cas9-mediated knock-in of BRCA1/2 mutations restores response to olaparib in pancreatic cancer cell lines.

Journal: Scientific reports

Published: October 18, 2022

Showing 1-12 of 15

Last Updated: 09/26/2026